Profile data is unavailable for this security.
About the company
Incannex Healthcare Inc. is a clinical-stage pharmaceutical development company. The Company is developing medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for the treatment of obstructive sleep apnea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, and pain, among other indications. The Company’s diversified portfolio includes 28 distinct research and development (R&D) programs, and six clinical trials underway. Its clinical projects include IHL-42X Obstructive Sleep Apnea, IHL-675A Inflammatory Lung Disease, IHL-675A Rheumatoid Arthritis, IHL-675A Inflammatory Bowel Disease, IHL-216A Concussion and TBI, PSI-GAD Psilocybin for anxiety, MedChew GB Post-herpatic Neuralgia and MedChew -1401 Pain and Spasticity in Multiple Sclerosis.
- Revenue in USD (TTM)--
- Net income in USD--
- Incorporated2023
- Employees--
- LocationIncannex Healthcare Inc18 East 50th Street, 5th FloorNEW YORK 10022United StatesUSA
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aadi Bioscience Inc | 23.84m | -68.83m | 34.38m | 75.00 | -- | 0.38 | -- | 1.44 | -2.55 | -2.55 | 0.8848 | 3.68 | 0.1692 | 0.6021 | 4.54 | 267,865.20 | -48.86 | -50.25 | -56.39 | -56.15 | 87.70 | -- | -288.72 | -473.97 | 4.86 | -- | 0.00 | -- | 60.06 | 3.85 | -8.68 | -- | 153.54 | -- |
| Natural Alternatives International, Inc. | 120.20m | -3.31m | 34.48m | 317.00 | -- | 0.41 | 25.69 | 0.2868 | -0.5646 | -0.5646 | 20.53 | 13.56 | 0.8091 | 3.63 | 12.77 | 379,183.00 | -2.23 | 4.90 | -2.56 | 5.93 | 8.85 | 15.98 | -2.75 | 3.80 | 2.44 | -2.71 | 0.0996 | 0.00 | -9.91 | 3.06 | -76.46 | -20.74 | 27.08 | -- |
| Cyclo Therapeutics Inc | 1.13m | -19.39m | 34.91m | 8.00 | -- | 57.23 | -- | 30.99 | -1.03 | -1.03 | 0.0557 | 0.0213 | 0.2001 | 0.4155 | 11.12 | 140,806.30 | -344.43 | -132.22 | -17,225.46 | -215.17 | 91.02 | 90.37 | -1,721.63 | -1,114.04 | 0.968 | -- | 0.00 | -- | -21.76 | 1.25 | -29.81 | -- | -3.95 | -- |
| Lexaria Bioscience Corp | 404.72k | -5.44m | 37.81m | 5.00 | -- | 5.02 | -- | 93.43 | -0.6851 | -0.6851 | 0.0493 | 0.5264 | 0.0722 | -- | 1.64 | 80,944.00 | -97.62 | -95.67 | -94.18 | -96.58 | 95.66 | 76.98 | -1,351.64 | -1,612.76 | -- | -175.33 | 0.00 | -- | -11.43 | -12.19 | 8.31 | -- | -- | -- |
| Fortress Biotech Inc | 85.11m | -62.86m | 39.50m | 186.00 | -- | 1.48 | -- | 0.464 | -6.65 | -6.65 | 7.96 | 1.19 | 0.3976 | 2.27 | 4.55 | 457,602.20 | -64.47 | -52.50 | -107.85 | -99.46 | 68.25 | 63.17 | -162.17 | -236.94 | 1.21 | -10.18 | 1.07 | -- | 11.58 | 25.75 | 27.42 | -- | -9.37 | -- |
| Qilian International Holding Group Ltd | 46.47m | -7.78m | 40.25m | 298.00 | -- | 0.9407 | -- | 0.8662 | -1.09 | -1.09 | 6.50 | 5.98 | 0.8027 | 6.45 | 33.30 | 155,944.60 | -14.03 | 2.71 | -16.84 | 3.86 | 3.77 | 11.66 | -17.48 | 2.72 | 4.43 | -0.4812 | 0.0107 | 26.11 | -28.35 | -1.60 | -822.64 | -- | 12.86 | -- |
| Ocuphire Pharma Inc | 19.01m | -11.30m | 40.96m | 14.00 | -- | 0.8606 | -- | 2.15 | -0.4867 | -0.4867 | 0.8366 | 1.84 | 0.391 | -- | 4.52 | 1,357,929.00 | -23.24 | -58.31 | -25.89 | -65.94 | -- | -- | -59.44 | -137.92 | -- | -7.80 | 0.00 | -- | -52.20 | -- | -155.83 | -- | -- | -- |
| Eyenovia Inc | 8.78k | -32.44m | 42.23m | 57.00 | -- | 20.03 | -- | 4,809.50 | -0.7448 | -0.7448 | 0.0002 | 0.0384 | 0.0003 | -- | 0.008 | 154.04 | -116.94 | -80.31 | -190.14 | -117.70 | 0.00 | -- | -369,519.70 | -680.95 | 0.6645 | -16.03 | 0.8914 | -- | -- | -- | 2.68 | -- | 152.20 | -- |
| Incannex Healthcare Inc | -100.00bn | -100.00bn | 43.49m | -- | -- | 3.08 | -- | -- | -- | -- | -- | 0.8907 | -- | -- | -- | -- | -- | -54.94 | -- | -59.47 | -- | -- | -- | -1,033.07 | -- | -- | 0.00 | -- | 61.92 | 3.38 | -24.35 | -- | 54.12 | -- |
| United-Guardian, Inc. | 11.57m | 2.75m | 44.03m | 25.00 | 16.01 | 3.94 | 15.42 | 3.81 | 0.5987 | 0.5987 | 2.52 | 2.43 | 0.926 | 3.17 | 6.40 | 462,790.80 | 22.02 | 29.84 | 25.94 | 34.39 | 48.64 | 55.31 | 23.78 | 28.79 | 5.99 | -- | 0.00 | 97.37 | -14.28 | -4.14 | 0.4616 | -9.92 | 17.19 | -19.73 |
| Bright Green Corp | 0.00 | -11.46m | 49.82m | 5.00 | -- | 4.48 | -- | -- | -0.0631 | -0.0631 | 0.00 | 0.0584 | 0.00 | -- | -- | 0.00 | -56.05 | -- | -84.87 | -- | -- | -- | -- | -- | -- | -18,125.84 | 0.0289 | -- | -- | -- | 52.54 | -- | -- | -- |
| Odonate Inc | 0.00 | -102.07m | 50.02m | 137.00 | -- | 1,844.41 | -- | -- | -13.59 | -13.59 | 0.00 | 9.27 | 0.00 | -- | -- | 0.00 | -66.98 | -58.36 | -83.00 | -65.14 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -12.99 | -- | -- | -- |
| Turnstone Biologics Corp | 0.00 | -74.92m | 52.04m | 82.00 | -- | 0.6504 | -- | -- | -3.53 | -3.53 | 0.00 | 3.46 | 0.00 | -- | -- | 0.00 | -80.25 | -- | -94.45 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -73.66 | -- | -78.05 | -- | -- | -- |
| Rockwell Medical Inc | 86.62m | -8.42m | 53.60m | 237.00 | -- | 2.53 | -- | 0.6188 | -0.3584 | -0.3584 | 3.33 | 0.6984 | 1.90 | 13.28 | 10.12 | 365,485.20 | -18.47 | -46.29 | -27.53 | -65.38 | 10.59 | 4.66 | -9.72 | -36.51 | 1.38 | -3.54 | 0.331 | -- | 14.84 | 5.69 | 54.82 | -- | 76.21 | -- |
Data as of Jul 03 2024. Currency figures normalised to Incannex Healthcare Inc's reporting currency: US Dollar USD
4.03%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Tidal Investments LLCas of 31 Mar 2024 | 423.41k | 2.67% |
| HRT Financial LLCas of 31 Mar 2024 | 82.97k | 0.52% |
| AdvisorShares Investments LLCas of 31 Mar 2024 | 50.92k | 0.32% |
| Morgan Stanley & Co. LLCas of 31 Mar 2024 | 29.85k | 0.19% |
| Jane Street Capital LLCas of 31 Mar 2024 | 20.44k | 0.13% |
| Citadel Securities LLCas of 31 Mar 2024 | 13.73k | 0.09% |
| Virtu Americas LLCas of 31 Mar 2024 | 10.81k | 0.07% |
| UBS Securities LLCas of 31 Mar 2024 | 2.92k | 0.02% |
| Tower Research Capital LLCas of 31 Mar 2024 | 2.13k | 0.01% |
| Qube Research & Technologies Ltd.as of 31 Mar 2024 | 2.10k | 0.01% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
